New eye drop for dry eye compared to existing solution
Part of Eyes & vision clinical trials.
This study tests a new eye drop solution (PRO-240) compared to an existing one (Optive) in healthy adults. It aims to see how safe and comfortable the new drops are for dry eye relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your eyes must be generally healthy with no active eye diseases, and you must not have had eye surgery in the last 6 months.
- You cannot have used any eye drops or other medications (including pain relievers or antibiotics) within the last 30 days.
- You cannot have worn contact lenses in the two weeks before starting the study or during the study.
- You must not have chronic conditions like diabetes, high blood pressure, heart or liver disease, or glaucoma.
- You must be a non-smoker and not drink alcohol during the study period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether BUFY01 eye drops work better than SVS20 for treating dry eye disease. You may be able to join if you have dry eye symptoms for at least 3 months and meet eye exam score and tear-test requirements.
This trial compares two different dry-eye eye drops to see which works better and is safe. You may be able to join if you’ve had dry eye for at least 3 months and meet specific eye-test results.
This trial tests a medical device eye ointment called Vit-A-Vision for people with dry eye disease. It aims to see if the ointment can improve symptoms and tear film stability over about a month.
This study tests a new eye drop called PRO-190 to see if it's safe and comfortable for the eyes, comparing it to a common artificial tear (Systane Ultra). It is for healthy people and may help if you have dry or irritated eyes.
This trial tests a new eye drop (0.4% solution) to see if it's safe and effective for people with dry eye. It's for both contact lens wearers and non-wearers who have dry eye symptoms, and aims to find a better way to relieve discomfort.
This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.
Hear when a new Ocular Surface Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.